|
Quotes & Info
|
| PRA > SEC Filings for PRA > Form 10-Q on 6-Nov-2007 | All Recent SEC Filings |
6-Nov-2007
Quarterly Report
Reinsurance
We use insurance and reinsurance (collectively, "reinsurance") to provide
capacity to write larger limits of liability, and to stabilize underwriting
results in years in which higher losses occur. The purchase of reinsurance does
not relieve us from the ultimate risk on our policies, but it does provide
reimbursement from the reinsurer for certain losses we pay.
We evaluate each of our ceded reinsurance contracts at inception to determine
if there is sufficient risk transfer to allow the contract to be accounted for
as reinsurance under current accounting guidance. At September 30, 2007 all
ceded contracts are accounted for as risk transferring contracts.
Our receivable from reinsurers on unpaid losses and loss adjustment expenses
represents our estimate of the amount of our reserve for losses that will be
recoverable under our insurance and reinsurance programs. We base our estimation
of funds recoverable upon our expectation of ultimate losses and the portion of
those losses that we estimate to be allocable to reinsurers based upon the terms
of our reinsurance agreements. As losses are paid, the related amount expected
to be collected from reinsurers is recorded as a receivable in other assets as
it no longer relates to our recorded reserves.
We estimate premiums ceded under reinsurance agreements wherein the premium
due to the reinsurer, subject to certain maximums and minimums, is based on
losses reimbursed or to be reimbursed under the agreement. Our estimates of the
amounts due from and to reinsurers are regularly reviewed and updated by
management as new data becomes available. Our assessment of the collectibility
of the recorded amounts receivable from reinsurers considers the payment history
of the reinsurer, publicly available financial and rating agency data, our
interpretation of the underlying contracts and policies, and responses by
reinsurers. Appropriate reserves are established for balances we believe may not
be ultimately collected.
Given the uncertainty of the ultimate amounts of our losses, our estimates of
losses and related amounts recoverable may vary significantly from the eventual
outcome. Any adjustments are reflected in then-current operations. Due to the
size of our reinsurance balances, even a small adjustment to these estimates
could have a material effect on our results of operations for the period in
which the adjustment is made.
Investment Valuations
We evaluate our investments on at least a quarterly basis for declines in
fair value below cost for the purpose of determining whether these declines
represent other than temporary declines. Some of the factors we consider in the
evaluation of our investments are:
- the extent to which the fair value of the investments is less than its
cost basis,
- the length of time for which the fair value of the investment has been less than its cost basis,
- the financial condition and near-term prospects of the issuer underlying the investment, taking into consideration the economic prospects of the issuer's industry and geographical region, to the extent that information is publicly available, and
- our ability and intent to hold the investment for a period of time sufficient to allow for any anticipated recovery in fair value.
When we judge a decline in fair value below cost to be other than temporary
we reduce the cost basis of the investment to fair value and realize a loss in
the current period income statement for the amount of the reduction. In
subsequent periods, we base any measurement of gain or loss or decline in value
upon the adjusted cost basis of the investment.
Deferred Policy Acquisition Costs
Policy acquisition costs, primarily commissions, premium taxes and
underwriting salaries, vary directly with, and are primarily related to, the
acquisition of new and renewal premiums. Such costs are capitalized and charged
to expense as the related premium revenue is recognized. We evaluate the
recoverability of our deferred policy acquisition costs and any amounts
estimated to be unrecoverable are charged to expense in the current period.
Accounting Changes
We adopted FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes, an interpretation of FAS 109, Accounting for Income Taxes (FIN 48) as of
its effective date, January 1, 2007. FIN 48 creates a single model to address
accounting for uncertainty in tax positions and clarifies the accounting for
income taxes by prescribing a minimum recognition threshold that a tax position
is required to meet before being recognized in the financial statements. FIN 48
also provides guidance on derecognition, measurement, classification, interest
and penalties, accounting for interim periods, disclosure and transition. The
cumulative effect of adopting FIN 48 increased retained earnings and reduced our
tax liability by $2.7 million.
Recent Accounting Pronouncements and Guidance
In September 2006, the Financial Accounting Standards Board (FASB) issued
Statement of Financial Accounting Standard (SFAS) 157, Fair Value Measurements
(SFAS 157). The standard establishes a framework for measuring fair value under
GAAP and expands disclosures about fair value measurements. SFAS 157 is
applicable to other accounting pronouncements that require or permit fair value
measurements but does not require any new fair value measurements. The statement
is effective for fiscal years beginning after November 15, 2007, unless early
adopted. We will adopt SFAS 157 on its effective date, and do not expect the
implementation of SFAS 157 to have a material effect on our results of
operations or financial condition.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for
Financial Assets and Financial Liabilities-Including an Amendment of FASB
Statement No. 115 (SFAS 159). SFAS 159 allows many financial assets and
liabilities and other items to be reported at fair value that are not currently
measured at fair value; unrealized gains and losses on items for which the fair
value option has been elected would be reported in earnings at each subsequent
reporting date. SFAS 159 also establishes new disclosure requirements with
respect to fair values. SFAS 159 is effective for fiscal years beginning after
November 15, 2007, unless early adopted. We will adopt SFAS 159 on its effective
date, but have not completed our determination of the effect of adoption on our
results of operations or financial condition.
Recent Significant Events
Effective January 1, 2006, we sold our personal lines operations and
recognized a gain on the sale of $109.4 million after consideration of sales
expenses and estimated taxes. Additional information regarding the sale is
provided in Note 3, "Discontinued Operations" of the Notes to the Condensed
Consolidated Financial Statements.
Effective August 1, 2006 we acquired Physicians Insurance Company of
Wisconsin, Inc. (PIC Wisconsin) in an all stock merger. The acquisition of PIC
Wisconsin allowed ProAssurance to expand its medical professional liability
business into the state of Wisconsin and adjacent states and into Nevada. This
transaction strategically expanded our geographic footprint and was in keeping
with our desire to expand our professional liability operations through
selective acquisitions. A more detailed description of the merger transaction is
provided in Note 2 of the Notes to the Condensed Consolidated Financial
Statements.
During the first quarter of 2007 we reached a confidential settlement that
ended all litigation and appeals stemming from, and related to, a $217 million
judgment on a malpractice verdict against insureds of one of our subsidiaries
entered in Tampa, Florida in October 2006. The effect of the settlement has been
reflected in our financial statements.
On April 2, 2007 our Board authorized $150 million to repurchase our shares
or debt securities. The timing and quantity of any repurchase is dependent upon
market conditions and any changes in ProAssurance's capital requirements, as
well as limitations imposed by applicable securities laws and regulations, and
the rules of the New York Stock Exchange. As of September 30, 2007 we have
repurchased approximately 764,000 common shares at a total cost of approximately
$41.3 million. On October 15, 2007 we announced our decision to utilize
$16 million of the authorization to redeem our outstanding 2032 Subordinated
Debentures on December 4, 2007.
A. Derrill Crowe, M.D. retired as Chief Executive Officer (CEO), effective
July 1, 2007 and remains as non-executive Chairman of our Board. The Board of
Directors elected W. Stancil Starnes to succeed Dr. Crowe as CEO. Mr. Starnes
formerly served as President, Corporate Planning and Administration, of
Brasfield & Gorrie, LLC, a large commercial construction firm. Prior to October
2006, Mr. Starnes served as the Senior and Managing Partner of Starnes &
Atchison, LLP, Attorneys at Law, and was extensively involved with ProAssurance
and its predecessor companies in the defense of its medical liability claims.
Reclassifications
Due to the increasing significance of the amounts involved, we have
separately stated our investments in unconsolidated subsidiaries and our equity
in the earnings of unconsolidated subsidiaries. Previously, investments in
unconsolidated subsidiaries were included as a component of other investments,
and earnings of unconsolidated subsidiaries were considered as a component of
net investment income. The reclassification had no effect on income from
continuing operations, net income or total assets.
Liquidity and Capital Resources and Financial Condition
Overview
ProAssurance Corporation is a holding company and is a legal entity separate
and distinct from its subsidiaries. Because it has no other business operations,
dividends from its operating subsidiaries represent a significant source of
funds for its obligations, including debt service. The ability of our insurance
subsidiaries to pay dividends is subject to limitation by state insurance
regulations. See our discussions under "Regulation of Dividends and Other
Payments from Our Operating Subsidiaries" in Part I, and in Note 15 of our Notes
to the Consolidated Financial Statements in our December 31, 2006 Form 10K for
additional information regarding dividend limitations. At September 30, 2007 we
held cash and investments of approximately $233 million outside of our insurance
subsidiaries that are available for use without regulatory approval.
Cash Flows
The principal components of our cash flow are the excess of net investment
income and premiums collected over net losses paid and operating costs,
including income taxes. Timing delays exist between the collection of premiums
and the ultimate payment of losses. Premiums are generally collected within the
twelve-month period after the policy is written while our claim payments are
generally paid over a more extended period of time. Likewise timing delays exist
between the payment of claims and the collection of reinsurance recoveries.
Our operating activities provided positive cash flows of approximately
$207.2 million during the nine months ended September 30, 2007, which is
composed of $163.6 million from routine insurance operations and proceeds of
$43.6 million related to the sale of trading securities. In 2006, cash provided
by operating activities of $134.5 million is composed of net positive cash flows
from routine insurance operations of $236.4 million, offset by tax payments
related to the sale of our personal lines operations of approximately
$54.6 million and purchases of trading securities of approximately
$47.4 million.
Exclusive of cash flows related to trading securities and the taxes paid on
the MEEMIC transaction, the decline in operating cash flows during 2007 is
principally attributable to an increase in payments for losses and loss
adjustment expenses (gross loss payments), net of reinsurance reimbursements
received (net loss payments). A number of factors influenced the growth in
losses paid, including the maturing of the loss reserves established during the
last several years of growth, and an increase in the number of large indemnity
payments.
Two metrics commonly used to analyze the operating cash flows of insurance
companies are the paid-to-incurred ratio and the paid loss ratio.
Three Months Ended Nine Months Ended
September 30 September 30
2007 2006 2007 2006
Paid-to-incurred ratio(1) 98.2 % 59.7 % 94.5 % 60.0 %
Paid loss ratio(2) 63.8 % 45.5 % 66.7 % 45.9 %
|
(1) Net loss payments divided by net losses and loss adjustment expenses
(2) Net loss payments divided by net earned premiums
Our paid-to-incurred and paid loss ratios are higher in 2007 than in 2006,
primarily due to the 2007 increase in net loss payments. The ratios also
increased in 2007 because the denominators of each ratio (net losses and loss
adjustment expenses for the paid-to-incurred ratio; net earned premiums for the
paid loss ratio) decreased in 2007 as compared to 2006. For a long-tailed
business such as ProAssurance, the ratios for a short period of time should not
be viewed in isolation. And, the ratios are less meaningful in periods of
changing volume or in periods in which we have recorded amounts related to prior
accident years.
The timing of our indemnity payments are affected by many factors, including
the nature of the claims in process in any one period and the speed at which
cases work through the trial and appellate process. The contractual obligations
table included in our December 31, 2006 Form 10K included a projected pay out
schedule for our December 31, 2006 reserves. In that table, which was largely
based on historical payment patterns, we projected gross loss payments of
approximately $546 million during 2007. To-date in 2007, our gross loss payments
total approximately $349 million, which, when annualized, is consistent with the
amount estimated for purposes of the table.
Cash flows in 2007 were also reduced due to a decline in premium receipts.
These decreases to operating cash flows were partially offset by growth in cash
flows from investment earnings, a reduction in premium payments to our
reinsurers and lower federal tax payments.
Investments
We manage our investments to ensure that we will have sufficient liquidity to
meet our obligations, taking into consideration the timing of cash flows from
our investments as well as the expected cash flows to be generated by our
operations. At our insurance subsidiaries the primary outflow of cash is related
to the payment of claims and expenses. The payment of individual claims cannot
be predicted with certainty; therefore, we rely upon the history of paid claims
in estimating the timing of future claims payments. To the extent that we have
an unanticipated shortfall in cash we may either liquidate securities or borrow
funds under previously established borrowing arrangements. However, given the
relatively short duration of our investments, we do not foresee any such
shortfall.
We held cash and short-term securities of $281.7 million at September 30,
2007 as compared to $213.4 million at December 31, 2006. Since December 31, 2006
we have chosen to hold more funds in our short-term portfolio both as a means of
managing the duration of our overall investment portfolio, and as a means of
increasing our flexibility in a volatile marketplace.
During the third quarter of 2007 we sold the securities held in our fixed
maturities trading portfolio (primarily treasury indexed) because we believed
active trading of these securities no longer offered superior returns.
Other investments increased from $39.5 million at December 31, 2006 to
$58.4 million at September 30, 2007. In January 2007 we contributed high-yield
asset-backed bonds from our available-for-sale investment portfolio to a fund
created for the purpose of managing such investments. We maintain a direct
beneficial interest in securities originally contributed to the fund, which are
included in our Balance Sheet as a component of other investments at fair value
($18.7 million at September 30, 2007). Cash flows from our initial investment in
the fund, which approximate $8.2 million to-date at September 30, 2007, are
being re-invested in an undivided interest of the fund. The undivided interest
is considered as an investment in an unconsolidated subsidiary and is accounted
for using the equity method.
As of September 30, 2007 our available-for-sale fixed maturity securities of
$3.20 billion comprise 88% of our total investments. The approximate $60 million
net increase as compared to our December 31, 2006 holdings reflects the
investment of operating cash flows, offset by a decline in fair value
attributable to higher interest rates (as discussed below).
Substantially all of our fixed maturities are either United States government
agency obligations or investment grade securities as determined by national
rating agencies. Our available-for-sale fixed maturities have a dollar weighted
average rating of "AA+" at September 30, 2007. The weighted average effective
duration of our fixed maturity securities at September 30, 2007 is 4.24 years;
the weighted average effective duration of our fixed maturity securities and our
short-term securities combined is 3.92 years.
Changes in market interest rate levels generally affect our net income to the
extent that reinvestment yields are different than the yields on maturing
securities. Changes in market interest rates also affect the fair value of our
fixed maturity securities. On a pre-tax basis, at September 30, 2007 our
available-for-sale fixed maturity securities had net unrealized losses of
approximately $10.4 million with gross unrealized losses totaling $27.1 million
and gross unrealized gains of $16.7 million. At December 31, 2006, on a pre-tax
basis, our available-for-sale fixed maturity securities had net unrealized
losses of approximately $2.5 million with unrealized losses totaling
$25.2 million and unrealized gains totaling $22.7 million. Almost all of the
unrealized loss positions in our portfolio are interest-rate related. Due to the
duration of our overall portfolio and our positive operating cash flows, we
believe we have the ability and intent to hold these bonds to recovery of book
value or maturity and do not consider the declines in value to be other than
temporary. For a discussion of the potential effects that future changes in
interest rates may have on our investment portfolio see Item 3, "Quantitative
and Qualitative Disclosures about Market Risk."
Equity investments represent less than 1% of our total investments and less
than 2% of our capital at both September 30, 2007 and December 31, 2006. At
September 30, 2007, the carrying value of our equity investments (including
equities in our available-for-sale and trading portfolios) totaled $21.4 million
as compared to $14.9 million at December 31, 2006.
Reinsurance
At September 30, 2007 our reinsurance recoverable on unpaid losses is
$344.7 million. Our receivable from reinsurers on paid losses, which is
classified as a part of other assets, is $42.1 million.
We purchase reinsurance from a number of companies to mitigate concentrations
of credit risk. Our reinsurance broker assists us in the analysis of the credit
quality of our reinsurers. We base our reinsurance buying decisions on an
evaluation of the then-current financial strength, rating and stability of
prospective reinsurers. However, the financial strength of our reinsurers, and
their corresponding ability to pay us, may change in the future due to forces or
events we cannot control or anticipate.
We have not experienced significant difficulties in collecting amounts due
from reinsurers due to the financial condition of the reinsurer. Periodically,
reinsurers may dispute our claim for reimbursement from them. We have
established appropriate reserves for any balances that we believe may not be
ultimately collected. Should future events lead us to believe that any reinsurer
will not meet its obligations to us, adjustments to the amounts recoverable
would be reflected in the results of current operations. Such an adjustment has
the potential to be significant to the results of operations in the period in
which it is recorded, however, we would not expect such an adjustment to have a
material effect on our capital position or our liquidity.
Periodically, we reach commutation agreements with our reinsurers wherein we
agree to terminate an existing reinsurance contract(s) for a specified final
settlement. Premiums ceded and reinsurance recoveries are adjusted in the
current period as necessary to reflect the amounts specified in the commutation
agreement.
During the third quarter of 2007, we commuted all of our outstanding
reinsurance arrangements with Alea London Limited for approximately $2.0 million
in cash. The transaction decreased premiums ceded for the quarter by
approximately $1.9 million and decreased reinsurance recoveries by approximately
$0.4 million.
Debt
Our long-term debt at September 30, 2007 is comprised of the following.
in thousands, except %
First
Rate 2007 Redemption Date
Convertible Debentures 3.9%, fixed $ 105,899 July 2008
2034 Subordinated Debentures 9.4%, Libor adjusted 46,395 May 2009
2032 Subordinated Debentures 9.6%, Libor adjusted 15,464 December 2007
7.7%, fixed until May 2009*
2034 Surplus Notes May 2009 11,753
$ 179,511
|
* Subject to approval by the Wisconsin Commissioner of Insurance
Our Convertible Debentures may be converted at the option of holders when the
price of our common stock exceeds a specified price during 20 of the last
30 days of any quarter. Upon conversion, holders will receive 23.9037 shares of
common stock for each $1,000 principal amount of debentures surrendered for
conversion. The criterion allowing conversion was met during the quarter ended
September 30, 2007 and holders may convert through December 31, 2007. To-date,
no holders have requested conversion. If converted, we have the right to deliver
cash or a combination of cash and common stock, in lieu of common stock.
We intend to redeem the 2032 Subordinated Debentures in December, 2007.
A more detailed description of our debt is provided in Note 8 of the Notes to
the Condensed Consolidated Financial Statements.
Litigation
We are involved in various legal actions arising primarily from claims
against us related to insurance policies and claims handling, including, but not
limited to, claims asserted by our policyholders. Legal actions are generally
divided into two categories: Legal actions dealing with claims and claim-related
actions which we consider in our evaluation of our reserve for losses and legal
actions falling outside of these areas which we evaluate and reserve for
separately as a part of our Other Liabilities.
Claim-related actions are considered as a part of our reserving process under
the guidance provided by SFAS 60 Accounting and Reporting by Insurance
Enterprises. We evaluate the likely outcomes from these actions giving
. . .
|
|